VWF is a blood glycoprotein that plays a major role in blood coagulation, and is involved in hemostasis, specifically, platelet adhesion. Increased plasma levels in many cardiovascular, neoplastic, metabolic (e.g. diabetes), and connective tissue diseases are presumed to arise from adverse changes to the endothelium, and may predict an increased risk of thrombosis.